These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7911728)

  • 1. GM1 ganglioside partially rescues cultured dopaminergic neurons from MPP(+)-induced damage: dependence on initial damage and time of treatment.
    Stull ND; Schneider JS; Iacovitti L
    Brain Res; 1994 Mar; 640(1-2):308-15. PubMed ID: 7911728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM1 ganglioside improves dopaminergic markers of rat mesencephalic cultures treated with MPP+.
    Dalia A; Neff NH; Hadjiconstantinou M
    J Neurosci; 1993 Jul; 13(7):3104-11. PubMed ID: 8101212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine hydroxylase and aromatic L-amino acid decarboxylase in mesencephalic cultures after MPP+: the consequences of treatment with GM1 ganglioside.
    Dalia A; Neff NH; Hadjiconstantinou M
    Brain Res; 1996 Dec; 742(1-2):260-4. PubMed ID: 9117403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D; Unsicker K
    J Neurosci Res; 1993 Mar; 34(4):382-93. PubMed ID: 8097265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M; Mariani AP; Neff NH
    Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats.
    Goettl VM; Wemlinger TA; Duchemin AM; Neff NH; Hadjiconstantinou M
    Neuroscience; 1999; 92(3):991-1000. PubMed ID: 10426539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced restoration of striatal dopamine concentrations by combined GM1 ganglioside and neurotrophic factor treatments.
    Schneider JS; DiStefano L
    Brain Res; 1995 Mar; 674(2):260-4. PubMed ID: 7796105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture: selectivity and irreversibility.
    Michel PP; Dandapani BK; Knusel B; Sanchez-Ramos J; Hefti F
    J Neurochem; 1990 Apr; 54(4):1102-9. PubMed ID: 1968953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional changes in cocultures of mesencephalon and striatal neurons from embryonic C57/BL6 mice due to low concentrations of 1-methyl-4-phenylpyridinium (MPP+).
    Koutsilieri E; Chan WW; Reinitzer D; Rausch WD
    J Neural Transm Gen Sect; 1993; 94(3):189-97. PubMed ID: 7907217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.
    Michel PP; Agid Y
    Brain Res; 1992 Dec; 597(2):233-40. PubMed ID: 1361874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM1 ganglioside treatment partially reverses the nigrostriatal dopamine defect in the weaver mutant mouse.
    Schneider JS; Smith MG; DiStefano L; Berrian J
    Brain Res; 1994 Feb; 636(2):353-6. PubMed ID: 7912161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
    Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
    Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice.
    Schneider JS; Kean A; DiStefano L
    J Neurosci Res; 1995 Sep; 42(1):117-23. PubMed ID: 8531220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidence.
    Sanchez-Ramos JR; Michel P; Weiner WJ; Hefti F
    J Neurochem; 1988 Jun; 50(6):1934-44. PubMed ID: 2897430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
    Park TH; Mytilineou C
    Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
    Rothblat DS; Schneider JS
    Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP, but not basic FGF, increases the in vitro survival of mesencephalic dopaminergic neurons and protects them from MPP(+)-induced degeneration.
    Hartikka J; Staufenbiel M; Lübbert H
    J Neurosci Res; 1992 Jun; 32(2):190-201. PubMed ID: 1357186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons.
    Pong K; Doctrow SR; Baudry M
    Brain Res; 2000 Oct; 881(2):182-9. PubMed ID: 11036157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic GM1 ganglioside treatment reduces dopamine cell body degeneration in the substantia nigra after unilateral hemitransection in rat.
    Toffano G; Savoini GE; Moroni F; Lombardi G; Calzà L; Agnati LF
    Brain Res; 1984 Apr; 296(2):233-9. PubMed ID: 6142756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal cholinergic and dopaminergic deficits of aged rats are improved following treatment with GM1 ganglioside.
    Goettl VM; Wemlinger TA; Fong TG; Neff NH; Hadjiconstantinou M
    Brain Res; 2000 Sep; 877(1):1-6. PubMed ID: 10980236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.